Dr. McCormick is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1130 Nw 22nd Ave Ste 110
Portland, OR 97210Phone+1 503-413-8654Fax+1 503-413-8655- Is this information wrong?
Education & Training
- Johns Hopkins UniversityFellowship, Gynecologic Oncology, 2009
- Johns Hopkins UniversityResidency, Obstetrics and Gynecology, 2002 - 2006
- Mayo Clinic College of Medicine and Science (Rochester)Internship, Internal Medicine, 2001 - 2002
- Johns Hopkins University School of MedicineClass of 2001
Certifications & Licensure
- OR State Medical License 2009 - 2025
- NM State Medical License 2021 - 2025
- WA State Medical License 2009 - 2022
- MD State Medical License 2006 - 2011
- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Publications & Presentations
PubMed
- Progression-free survival and safety at 3.5 years of follow-up: results from the randomized phase 3 PRIMA/ENGOT-OV26/GOG-3012 trial of niraparib maintenance treatment ...Antonio González-Martín, Bhavana Pothuri, Ignace Vergote, Whitney Graybill, Domenica Lorusso, Colleen C McCormick, Gilles Freyer, Floor Backes, Florian Heitz, Andrés R...> ;Future Oncology. 2024 Mar 19
- 12 citationsProgression-free survival and safety at 3.5years of follow-up: results from the randomised phase 3 PRIMA/ENGOT-OV26/GOG-3012 trial of niraparib maintenance treatment i...Antonio González-Martín, Bhavana Pothuri, Ignace Vergote, Whitney Graybill, Domenica Lorusso, Colleen C McCormick, Gilles Freyer, Floor Backes, Florian Heitz, Andrés R...> ;European Journal of Cancer. 2023 Aug 1
- 9 citationsOlaparib treatment for platinum-sensitive relapsed ovarian cancer by BRCA mutation and homologous recombination deficiency status: Phase II LIGHT study primary analysis.Karen Cadoo, Fiona Simpkins, Cara Mathews, Ying L Liu, Diane Provencher, Colleen McCormick, Adam C ElNaggar, Alon D Altman, Lucy Gilbert, Destin Black, Nashwa Kabil, J...> ;Gynecologic Oncology. 2022 Sep 1
- Join now to see all
Press Mentions
- School Nurse Returns to ICU After ClosuresApril 29th, 2020
- Legacy Salmon Creek Study Featured in Medical JournalOctober 22nd, 2019
- Legacy Participates in Trial for Promising Ovarian Cancer Drug - Portland Business JournalOctober 2nd, 2019
Hospital Affiliations
- Legacy Emanuel Medical CenterPortland, Oregon
- Legacy Good Samaritan Medical CenterPortland, Oregon
- Providence Portland Medical CenterPortland, Oregon
- Providence St. Vincent Medical CenterPortland, Oregon
- Legacy Salmon Creek Medical CenterVancouver, Washington
- PeaceHealth Southwest Medical CenterVancouver, Washington
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: